Rescission of Social Security Ruling 93-2p; Policy Interpretation Ruling; Titles II and XVI: Evaluation of Human Immunodeficiency Virus Infection, 13914 [2017-05111]

Download as PDF 13914 Federal Register / Vol. 82, No. 49 / Wednesday, March 15, 2017 / Notices applicant has filed no other claims or appeals under the Title for which SSA obtained the authorization; • the individual’s eligibility for payments ends, and the individual has not filed other claims or appeals under the Title for which SSA obtained the authorization; • the individual revokes the authorization verbally or in writing; or • the deeming relationship ends (for SSI purposes only). SSA will request authorization on an as-needed basis as part of the following processes: (a) SSDI and SSI initial claims; (b) SSI redeterminations; and (c) SSDI Work Continuing Disability Number of respondents Modality of completion Reviews. The respondents are individuals who file for or are currently receiving SSDI or SSI payments, and any person whose income and resources SSA counts when determining an individual’s SSI eligibility or payment amount. Type of Request: Request for a new information collection. Average burden per response (minutes) Frequency of response Estimated total annual burden (hours) SSA–8240 (paper) ........................................................................................... Title II & Title XVI Electronic (MCS, MSSICS, and eWork) ............................ Internet ............................................................................................................. Revoking Authorization .................................................................................... 136,150 2,769,800 927,504 191,673 1 1 1 1 6 2 2 10 13,615 92,327 30,917 31,946 Totals ........................................................................................................ 4,025,127 ........................ ........................ 168,805 Dated: March 10, 2017. Naomi R. Sipple, Reports Clearance Officer, Social Security Administration. [FR Doc. 2017–05112 Filed 3–14–17; 8:45 am] BILLING CODE 4191–02–P SOCIAL SECURITY ADMINISTRATION [Docket No. SSA–2007–0082] Rescission of Social Security Ruling 93–2p; Policy Interpretation Ruling; Titles II and XVI: Evaluation of Human Immunodeficiency Virus Infection Social Security Administration. ACTION: Notice of rescission of Social Security Ruling, 93–2p. AGENCY: In accordance with 20 CFR 402.35(b)(1), the Acting Commissioner of Social Security gives notice of the rescission of Social Security Ruling (SSR) 93–2p. DATES: Effective Date: This rescission is effective March 15, 2017. FOR FURTHER INFORMATION CONTACT: Cheryl A. Williams, Office of Disability Policy, Office of Medical Policy, Social Security Administration, 6401 Security Boulevard, Baltimore, MD 21235–6401, (410) 966–4163. For information on eligibility or filing for benefits, call our national toll-free number 1–800–772– 1213, or TTY 1–800–325–0778, or visit our Internet site, Social Security online, at http://www.socialsecurity.gov. SUPPLEMENTARY INFORMATION: Through SSRs, we make available to the public precedential decisions relating to the Federal old-age, survivors, disability, supplemental security income, and special veterans benefits programs. We may base SSRs on determinations or decisions made at all levels of asabaliauskas on DSK3SPTVN1PROD with NOTICES2 SUMMARY: VerDate Sep<11>2014 18:19 Mar 14, 2017 Jkt 241001 administrative adjudication, Federal court decisions, Commissioner’s decisions, opinions of the Office of General Counsel, or other interpretations of the law and regulations. SSR 93–2p provides guidance about evaluating duration in cases meeting or equaling the human immunodeficiency virus (HIV) infection listings. It instructs that with acceptable documentation of HIV infection as described in the introductory text to the listings in the Immune body system, an individual who has an impairment that meets or equals one of the criteria in the listings for HIV infection has an impairment that is considered permanent or expected to result in death. In these cases, a separate durational finding is not required, and evidence showing that the impairment has lasted or expected to last for a continuous period of at least 12 months is unnecessary. On December 2, 2016, we published a final rule, Revised Medical Criteria for Evaluating Human Immunodeficiency Virus (HIV) Infection and for Evaluating Functional Limitations in Immune System Disorders, in the Federal Register at 81 FR 86915. The final rule revises the listing criteria under which we evaluate impairments related to HIV infection (14.11 for adults and 114.11 for children, formerly 14.08 and 114.08, respectively). These updates reflect the advances in medical treatment of and expected outcomes for people with HIV infection since we last revised our listings for HIV infection. At the time we originally published SSR 93–2p, medical outcomes for individuals infected with HIV were sufficiently unfavorable that we could reasonably assume that all impairments meeting or equaling the HIV listings either were permanent or would result in death. PO 00000 Frm 00127 Fmt 4703 Sfmt 4703 However, due to medical advances and the resulting updates to the criteria in the listings, this is no longer a proper assumption for us to make. The final rule became effective January 17, 2017. Id., at 86915. Consequently, we are rescinding SSR 93–2p as obsolete. (Catalog of Federal Domestic Assistance Programs Nos. 96.001, Social Security— Disability Insurance; 96.002, Social Security—Retirement Insurance; 96.004, Social Security—Survivors Insurance; 96.006—Supplemental Security Income) Nancy A. Berryhill, Acting Commissioner of Social Security. [FR Doc. 2017–05111 Filed 3–14–17; 8:45 am] BILLING CODE 4191–02–P DEPARTMENT OF STATE [Public Notice 9906] Cultural Property Advisory Committee; Notice of Meeting Department of State. Notice of meeting and request for comment from outside parties. AGENCY: ACTION: The Department of State is issuing this notice to announce the location, date, time and agenda for the next meeting of the Cultural Property Advisory Committee. DATES: • Written Comments: Must be received no later than March 20, 2017, at 11:59 p.m. (ET). • Open Session: March 21, 2017, 9:00 a.m. (EDT). • Closed Session: March 21–March 24, 2017. ADDRESSES: The open meeting will be held at the U.S. Department of State, SA–5 (American Pharmacists SUMMARY: E:\FR\FM\15MRN1.SGM 15MRN1

Agencies

[Federal Register Volume 82, Number 49 (Wednesday, March 15, 2017)]
[Notices]
[Page 13914]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-05111]


-----------------------------------------------------------------------

SOCIAL SECURITY ADMINISTRATION

[Docket No. SSA-2007-0082]


Rescission of Social Security Ruling 93-2p; Policy Interpretation 
Ruling; Titles II and XVI: Evaluation of Human Immunodeficiency Virus 
Infection

AGENCY: Social Security Administration.

ACTION: Notice of rescission of Social Security Ruling, 93-2p.

-----------------------------------------------------------------------

SUMMARY: In accordance with 20 CFR 402.35(b)(1), the Acting 
Commissioner of Social Security gives notice of the rescission of 
Social Security Ruling (SSR) 93-2p.

DATES: Effective Date: This rescission is effective March 15, 2017.

FOR FURTHER INFORMATION CONTACT: Cheryl A. Williams, Office of 
Disability Policy, Office of Medical Policy, Social Security 
Administration, 6401 Security Boulevard, Baltimore, MD 21235-6401, 
(410) 966-4163. For information on eligibility or filing for benefits, 
call our national toll-free number 1-800-772-1213, or TTY 1-800-325-
0778, or visit our Internet site, Social Security online, at http://www.socialsecurity.gov.

SUPPLEMENTARY INFORMATION: Through SSRs, we make available to the 
public precedential decisions relating to the Federal old-age, 
survivors, disability, supplemental security income, and special 
veterans benefits programs. We may base SSRs on determinations or 
decisions made at all levels of administrative adjudication, Federal 
court decisions, Commissioner's decisions, opinions of the Office of 
General Counsel, or other interpretations of the law and regulations.
    SSR 93-2p provides guidance about evaluating duration in cases 
meeting or equaling the human immunodeficiency virus (HIV) infection 
listings. It instructs that with acceptable documentation of HIV 
infection as described in the introductory text to the listings in the 
Immune body system, an individual who has an impairment that meets or 
equals one of the criteria in the listings for HIV infection has an 
impairment that is considered permanent or expected to result in death. 
In these cases, a separate durational finding is not required, and 
evidence showing that the impairment has lasted or expected to last for 
a continuous period of at least 12 months is unnecessary.
    On December 2, 2016, we published a final rule, Revised Medical 
Criteria for Evaluating Human Immunodeficiency Virus (HIV) Infection 
and for Evaluating Functional Limitations in Immune System Disorders, 
in the Federal Register at 81 FR 86915. The final rule revises the 
listing criteria under which we evaluate impairments related to HIV 
infection (14.11 for adults and 114.11 for children, formerly 14.08 and 
114.08, respectively). These updates reflect the advances in medical 
treatment of and expected outcomes for people with HIV infection since 
we last revised our listings for HIV infection. At the time we 
originally published SSR 93-2p, medical outcomes for individuals 
infected with HIV were sufficiently unfavorable that we could 
reasonably assume that all impairments meeting or equaling the HIV 
listings either were permanent or would result in death. However, due 
to medical advances and the resulting updates to the criteria in the 
listings, this is no longer a proper assumption for us to make. The 
final rule became effective January 17, 2017. Id., at 86915. 
Consequently, we are rescinding SSR 93-2p as obsolete.

(Catalog of Federal Domestic Assistance Programs Nos. 96.001, Social 
Security--Disability Insurance; 96.002, Social Security--Retirement 
Insurance; 96.004, Social Security--Survivors Insurance; 96.006--
Supplemental Security Income)

Nancy A. Berryhill,
Acting Commissioner of Social Security.
[FR Doc. 2017-05111 Filed 3-14-17; 8:45 am]
 BILLING CODE 4191-02-P